Back to Search Start Over

Pathogenicity of porcine deltacoronavirus (PDCoV) strain NH and immunization of pregnant sows with an inactivated PDCoV vaccine protects 5-day-old neonatal piglets from virulent challenge.

Authors :
Zhang J
Chen J
Liu Y
Da S
Shi H
Zhang X
Liu J
Cao L
Zhu X
Wang X
Ji Z
Feng L
Source :
Transboundary and emerging diseases [Transbound Emerg Dis] 2020 Mar; Vol. 67 (2), pp. 572-583. Date of Electronic Publication: 2019 Sep 30.
Publication Year :
2020

Abstract

In this study, the pathogenicity of porcine deltacoronavirus (PDCoV) strain NH (passage 10, P10) was evaluated. We found that PDCoV strain NH is enteropathogenic in 5-day-old pigs. Pathogenicity experiments provided a challenge model for studying the protection efficiency of passive immunity. In order to investigate the protective efficacy of passive immunity in newborn piglets, pregnant sows were vaccinated with either a PDCoV-inactivated vaccine at the Houhai acupoint (n = 5) or DMEM as a negative control (n = 2) using a prime/boost strategy 20 and 40 days before delivery. PDCoV spike (S)-specific IgG and neutralizing antibody (NA) responses were detected in immunized sows and piglets born to immunized sows. PDCoV spike (S)-specific sIgA was also detected in the colostrum and milk of immunized sows. Five days post-farrowing, piglets were orally challenged with PDCoV strain NH (10 <superscript>5</superscript> TCID <subscript>50</subscript> /piglet). Severe diarrhoea, high levels of viral RNA copies and substantial intestinal villus atrophy were detected in piglets born to unimmunized sows. Only 4 of 31 piglets (12.9%) born to immunized sows in the challenge group displayed mild to moderate diarrhoea, lower viral RNA copies and minor intestinal villi damage compared to piglets born to unimmunized sows post-challenge. Mock piglets exhibited no typical clinical symptoms. The challenge experiment results indicated that the inactivated PDCoV vaccine exhibited 87.1% protective efficacy in the piglets. These findings suggest that the inactivated PDCoV vaccine has the potential to be an effective vaccine, providing protection against virulent PDCoV.<br /> (© 2019 Blackwell Verlag GmbH.)

Details

Language :
English
ISSN :
1865-1682
Volume :
67
Issue :
2
Database :
MEDLINE
Journal :
Transboundary and emerging diseases
Publication Type :
Academic Journal
Accession number :
31541590
Full Text :
https://doi.org/10.1111/tbed.13369